{"count": 4, "results": [{"_id": "6129884", "pmid": 6129884, "title": "Effect of beta-adrenoceptor antagonists on prevalence of peripheral vascular symptoms in hypertensive patients.", "journal": "Br J Clin Pharmacol", "authors": ["Steiner JA", "Cooper R", "McPherson K", "Riley AJ"], "date": "1982-12-01T00:00:00Z", "doi": "10.1111/j.1365-2125.1982.tb02045.x", "meta_date_publication": "1982 Dec", "meta_volume": "14", "meta_issue": "6", "meta_pages": "833-7", "score": 50062.09, "text_hl": "Effect of beta-adrenoceptor antagonists on prevalence of @<m>DISEASE_Peripheral_Vascular_Diseases</m> @DISEASE_MESH:D016491 @@@peripheral vascular symptoms@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@.", "citations": {"NLM": "Steiner JA, Cooper R, McPherson K, Riley AJ. Effect of beta-adrenoceptor antagonists on prevalence of peripheral vascular symptoms in hypertensive patients. Br J Clin Pharmacol. 1982 Dec;14(6):833-7. PMID: 6129884", "BibTeX": "@article{6129884, title={Effect of beta-adrenoceptor antagonists on prevalence of peripheral vascular symptoms in hypertensive patients.}, author={Steiner JA and Cooper R and McPherson K and Riley AJ}, journal={Br J Clin Pharmacol}, volume={14}, number={6}, pages={833-7}}"}}, {"_id": "15775796", "pmid": 15775796, "title": "Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy.", "journal": "J Hypertens", "authors": ["Olsen MH", "Fossum E", "Høieggen A", "Wachtell K", "Hjerkinn E", "Nesbitt SD", "Andersen UB", "Phillips RA", "Gaboury CL", "Ibsen H", "Kjeldsen SE", "Julius S"], "date": "2005-04-01T00:00:00Z", "doi": "10.1097/01.hjh.0000163160.60234.15", "meta_date_publication": "2005 Apr", "meta_volume": "23", "meta_issue": "4", "meta_pages": "891-8", "score": 50060.258, "text_hl": "We hypothesized that treatment with @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ as compared to @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ would improve @GENE_INS @GENE_3630 @@@insulin@@@ sensitivity through regression of @<m>DISEASE_Peripheral_Vascular_Diseases</m> @DISEASE_MESH:D016491 @@@peripheral vascular hypertrophy@@@/rarefaction. ", "citations": {"NLM": "Olsen MH, Fossum E, Høieggen A, Wachtell K, Hjerkinn E, Nesbitt SD, Andersen UB, Phillips RA, Gaboury CL, Ibsen H, Kjeldsen SE, Julius S. Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy. J Hypertens. 2005 Apr;23(4):891-8. PMID: 15775796", "BibTeX": "@article{15775796, title={Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy.}, author={Olsen MH and Fossum E and Høieggen A and Wachtell K and Hjerkinn E and Nesbitt SD and Andersen UB and Phillips RA and Gaboury CL and Ibsen H and Kjeldsen SE and Julius S}, journal={J Hypertens}, volume={23}, number={4}, pages={891-8}}"}}, {"_id": "2439820", "pmid": 2439820, "title": "Pharmacological characteristics of beta blockers and their role in clinical practice.", "journal": "J Cardiovasc Pharmacol", "authors": ["McDevitt DG"], "date": "1986-01-01T00:00:00Z", "doi": "10.1097/00005344-198608006-00002", "meta_date_publication": "1986", "meta_volume": "8 Suppl 6", "meta_issue": "", "meta_pages": "S5-11", "score": 50043.387, "text_hl": "Cardioselectivity refers to the ability of some drugs, notably @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@, to block beta 1 receptors without blocking beta 2 receptors. ", "citations": {"NLM": "McDevitt DG. Pharmacological characteristics of beta blockers and their role in clinical practice. J Cardiovasc Pharmacol. 1986;8 Suppl 6():S5-11. PMID: 2439820", "BibTeX": "@article{2439820, title={Pharmacological characteristics of beta blockers and their role in clinical practice.}, author={McDevitt DG}, journal={J Cardiovasc Pharmacol}, volume={8 Suppl 6}, pages={S5-11}}"}}, {"_id": "9886905", "pmid": 9886905, "title": "Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).", "journal": "J Hypertens", "authors": ["Brown MJ", "Castaigne A", "de Leeuw PW", "Mancia G", "Rosenthal T", "Ruilope LM"], "date": "1998-12-01T00:00:00Z", "meta_date_publication": "1998 Dec", "meta_volume": "16", "meta_issue": "12 Pt 2", "meta_pages": "2113-6", "score": 50028.98, "text_hl": "This was followed by four optional increases in treatment: dose-doubling of the primary drug, addition of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ 25/50 mg or @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ 5/10 mg, and then any other @DISEASE_Hypotension @DISEASE_MESH:D007022 @@@hypotensive@@@ drug excluding calcium blockers or diuretics. ", "citations": {"NLM": "Brown MJ, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT). J Hypertens. 1998 Dec;16(12 Pt 2):2113-6. PMID: 9886905", "BibTeX": "@article{9886905, title={Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).}, author={Brown MJ and Castaigne A and de Leeuw PW and Mancia G and Rosenthal T and Ruilope LM}, journal={J Hypertens}, volume={16}, number={12 Pt 2}, pages={2113-6}}"}}]}